Abstract
Ushbu maqolada tuxumdon polikistoz sindromi (TPKS) bo‘yicha zamonaviy diagnostika va davolash usullarining tahlili berilgan. TPKS ayollar orasida keng tarqalgan endokrin buzilish bo‘lib, bepushtlik, gormonal nomutanosiblik va metabolik sindrom kabi salbiy oqibatlarga olib keladi. Maqolada sindromning klinik belgilarini aniqlash, ilg‘or diagnostik vositalar, shu jumladan genetik va molekulyar tadqiqotlar, hamda yangi terapevtik yondashuvlar ko‘rib chiqilgan.
References
1.Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility, 81(1), 19–25. https://doi.org/10.1016/j.fertnstert.2003.10.004
2.Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S., Legro, R. S., & Lizneva, D. (2016). Polycystic ovary syndrome. Nature Reviews Disease Primers, 2, 16057. https://doi.org/10.1038/nrdp.2016.57
3.Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., ... & Boyle, J. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction, 33(9), 1602–1618. https://doi.org/10.1093/humrep/dey256
4.Palomba, S., Santagni, S., Falbo, A., & La Sala, G. B. (2017). Complications and challenges associated with polycystic ovary syndrome: current perspectives. International Journal of Women's Health, 9, 623–635. https://doi.org/10.2147/IJWH.S125885
5.Genazzani, A. D., Santagni, S., & Ricchieri, F. (2020). Inositols in PCOS: from bench to bedside. Gynecological Endocrinology, 36(1), 1–6. https://doi.org/10.1080/09513590.2019.1680680
6.Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013). Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 98(12), 4565–4592. https://doi.org/10.1210/jc.2013-2350
7.Diamanti-Kandarakis, E., & Dunaif, A. (2012). Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocrine Reviews, 33(6), 981–1030. https://doi.org/10.1210/er.2011-1034
8.Moran, L. J., Pasquali, R., Teede, H. J., Hoeger, K. M., & Norman, R. J. (2009). Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertility and Sterility, 92(6), 1966–1982. https://doi.org/10.1016/j.fertnstert.2008.09.018
9.Li, X. J., Yu, Y. X., Liu, C. Q., Zhang, W., Zhang, H. J., & Zhang, C. (2020). Clinical efficacy of laparoscopic ovarian drilling in the treatment of polycystic ovary syndrome: a meta-analysis. Journal of Obstetrics and Gynaecology Research, 46(1), 1–12. https://doi.org/10.1111/jog.14147
